Free tool
FAERS Monitor: Nicorette
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018612 or its brand name (Nicorette, Nicotine Polacrilex). Reports on generic versions are filed under their own applications.
Reports
21,925
Serious
3,984
18% of reports
Hospitalization
924
Death reported
149
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective3,651
- nicotine dependence3,383
- intentional drug misuse3,276
- nausea1,926
- drug administration error1,140
- malaise1,015
- oral discomfort715
- dizziness703
- dyspepsia662
- wrong technique in product usage process656
- product quality issue652
- headache633
- vomiting620
- throat irritation614
- hiccups598
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 115 |
| 2005 | 223 |
| 2006 | 1,148 |
| 2007 | 1,347 |
| 2008 | 1,063 |
| 2009 | 1,094 |
| 2010 | 1,044 |
| 2011 | 1,453 |
| 2012 | 1,517 |
| 2013 | 1,109 |
| 2014 | 233 |
| 2015 | 1,570 |
| 2016 | 1,309 |
| 2017 | 1,308 |
| 2018 | 1,145 |
| 2019 | 1,038 |
| 2020 | 921 |
| 2021 | 1,062 |
| 2022 | 811 |
| 2023 | 725 |
| 2024 | 600 |
| 2025 | 707 |
| 2026 | 383 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,032,234 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| nicotine dependenceSignal | 3,383 | 737.1 | 706.2 | 1,406,333 |
| intentional drug misuseSignal | 3,276 | 178.0 | 171.9 | 486,733 |
| hiccupsSignal | 598 | 75.3 | 69.4 | 40,598 |
| oral discomfortSignal | 715 | 52.0 | 48.3 | 33,884 |
| drug administration errorSignal | 1,140 | 37.0 | 34.9 | 38,436 |
| throat irritationSignal | 614 | 13.3 | 12.3 | 6,889 |
| dyspepsiaSignal | 662 | 6.5 | 6.0 | 3,064 |
| product quality issueSignal | 652 | 4.6 | 4.3 | 1,850 |
| wrong technique in product usage processSignal | 656 | 3.1 | 2.9 | 944 |
| drug ineffectiveSignal | 3,651 | 2.7 | 2.6 | 4,029 |
| nauseaSignal | 1,926 | 2.3 | 2.2 | 1,527 |
| malaiseSignal | 1,015 | 2.2 | 2.1 | 695 |
| dizziness | 703 | 1.4 | 1.3 | 66 |
| vomiting | 620 | 1.3 | 1.2 | 35 |
| headache | 633 | 1.0 | 0.9 | 1 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.